Multi-Gene Prognostic Signatures and Prediction of Pathological Complete Response to Neoadjuvant Chemotherapy in ER-Positive, HER2-Negative Breast Cancer Patients

Determining which patients with early-stage breast cancer should receive chemotherapy is an important clinical issue. Chemotherapy has several adverse side effects, impacting on quality of life, along with significant economic consequences. There are a number of multi-gene prognostic signatures for...

Descripción completa

Detalles Bibliográficos
Autores principales: Mazo, Claudia, Barron, Stephen, Mooney, Catherine, Gallagher, William M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281334/
https://www.ncbi.nlm.nih.gov/pubmed/32369904
http://dx.doi.org/10.3390/cancers12051133

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281334/
https://www.ncbi.nlm.nih.gov/pubmed/32369904
http://dx.doi.org/10.3390/cancers12051133

Ejemplares similares